Associate Professor, Department of Pathology and Laboratory Medicine, University of Pennsylvania
Previously responsible for the product/process development of Kymriah, the world’s first CAR-T cell therapy approved by FDA
Early inventor and pioneer in CAR-T cell therapy
In-depth experience in immunology and immunotherapy, approaches to improving the anti-tumor efficacy of gene-engineered T cells for the treatment of cancers
Over 10 years of working experience in the National Institutes of Health (NIH)
Member of Chinese Academy of Sciences
Director and Professor, Institute for Immunology, Tsinghua University
Fellow of the American Association for the Advancement of Science
The 2009 American Society of Immunologists-BD Biosciences Investigator Award, the 2019 International Cytokine and Interferon Society Biolegend-William E. Paul Award
Specialty Chief Editor for Frontiers in Immunology, T Cell Biology, Associate Chief Editor for China Science Life Sciences, and Editorial Board Member of Immunity
Published more than 200 papers in immunology field, and was recognized as a “Highly Cited Scientist” in the world for seven consecutive years from 2014 to 2020
Chair and Professor, Department of Hematologic Malignancies Translational Science; Director, Gehr Family Center for Leukemia Research; Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope
Former Professor of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, and Pharmaceutics Division Hematology, Comprehensive Cancer Center and The Ohio State University
Member of the editorial board for several journals; published more than 270 peer-reviewed articles and research papers
